Non-selective β-blockers reduce bacterial translocation by restoring gut barrier function during experimental cirrhosis.
Journal of hepatology
View this publicationJournal of hepatology
View this publicationImmunity
View this publicationEuropean journal of immunology
View this publicationCell host & microbe
View this publicationMethods in molecular biology (Clifton, N.J.)
View this publicationNature communications
View this publication